Vaginitis: Review on Drug Resistance

Area of Science:

• Gynecology
• Infectious Diseases
• Pharmacology

Background:

• Female genital tract infections, including vaginitis (trichomoniasis, bacterial vaginosis, vulvovaginal candidiasis), are highly prevalent.
• These infections cause significant discomfort, pregnancy complications, and increase HIV transmission risk.
• Increasing antimicrobial resistance in pathogens like *Trichomonas vaginalis*, *Candida* spp., and *Gardnerella vaginalis* complicates treatment and leads to recurrent infections.

Purpose of the Study:

• To review drug resistance mechanisms against common vaginitis pathogens.
• To discuss pathogenesis and current treatment strategies for vaginitis.
• To inform the development of novel therapeutic agents and alternative therapies to combat drug resistance and reduce infection recurrence.

Main Methods:

• Literature review of existing studies on vaginitis pathogens.
• Analysis of antimicrobial resistance mechanisms.
• Discussion of pathogenesis and treatment options.

Main Results:

• Identified increasing resistance of *Trichomonas vaginalis*, *Candida* spp., and *Gardnerella vaginalis* to existing therapies.
• Highlighted the impact of drug resistance on treatment effectiveness and infection recurrence.
• Summarized current understanding of vaginitis pathogenesis and treatment limitations.

Conclusions:

• Drug resistance poses a significant challenge in treating female genital tract infections.
• Development of alternative therapies and novel drug design is crucial to overcome resistance.
• Effective treatments will reduce infection recurrence, improve women's health, and decrease healthcare costs.